Allianz Global Investors - Global Equity Business Unit

  • Land: Deutschland

Nachricht vom 14.08.2012 | 13:38

Allianz Global Investors - Global Equity Business Unit: Titan International Inc


Allianz Global Investors - Global Equity Business Unit  / Rule 8.3

14.08.2012 13:38

Dissemination of a UK Regulatory Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the 'Code')
 
1. KEY INFORMATION

(a) Identity of the person whose positions/dealings     Allianz Global
are being disclosed:                                    Investors Global
                                                        Equity Business
                                                        Unit
(b) Owner or controller of interests and short
positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is 
insufficient
 
(c) Name of offeror/offeree in relation to whose        Titan International
relevant securities this form relates:                  Inc
Use a separate form for each offeror/offeree            (US88830M1027)
                                                        
 
(d) If an exempt fund manager connected with an offeror/
offeree, state this and specify identity of offeror/
offeree:
 
(e) Date position held/dealing undertaken:              13 August 2012
 
(f) Has the discloser previously disclosed,             No   
or are they today disclosing, under the             
Code in respect of any other party to this
offer?                                                       
                                                    
                                                    
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
(a) Interests and short positions in the relevant securities of the
 offeror or offeree to which the disclosure relates following the dealing 
(if any)

 
Class of relevant security:            Ordinary Shares

                                       Interests           Short positions
                                       Number       %      Number      %
 
(1) Relevant securities owned and/or   1,366,007   3.098
controlled:
 
(2) Derivatives (other than options):
 
(3) Options and agreements to purchase/
sell:
 
TOTAL:                                 1,366,007   3.098

 
All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to
purchase or sell relevant securities, should be given on a Supplemental
Form 8 (Open Positions).
 
(b) Rights to subscribe for new securities (including directors' and other
executive options)
 
 
Class of relevant security in relation 
to which subscription right exists:
 
Details, including nature of the rights 
concerned and relevant percentages:

 
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
 
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
(a) Purchases and sales
 
 

Class of relevant        Purchase/sale  Number of       Price per
security                                securities      unit
Common Stock             Sale           4,495          USD 21.89
 

(b) Derivatives transactions (other than options)
 
 
Class of   Product    Nature of dealing e.g. opening/   Number of   Price
relevant   descript   closing a long/short position,    reference   per
security   ion e.g.   increasing/reducing a long/short  securities  unit
           CFD        position
 

 
(c) Options transactions in respect of existing securities
 
(i) Writing, selling, purchasing or varying
 
  
Class   Product   Writing,   Number of   Exerc   Type e.g.  Ex-  Option
of      descrip-  purchasi   securities  ise     American,  piry money
rele-   tion e.g. ng,        to which    price   European   da-  paid/
vant    call      selling,   option      per     etc.       te   received
secu-   option    varying    relates     unit                    per unit
rity              etc.
 

 
(ii) Exercising
 
 
Class of relevant  Product descriptione.g.  Number of      Exercise price
security           call option              securities     per unit

  
  
(d) Other dealings (including subscribing for new securities)
 
 
Class of relevant Nature of dealing e.g.     Details   Price per unit (if
security          subscription, conversion             applicable)
 


The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant
securities of the offeror or offeree named in 1(c), copy table 3(a), (b),
(c) or (d) (as appropriate) for each additional class of relevant security
dealt in.
 

4. OTHER INFORMATION
 
(a) Indemnity and other dealing arrangements
 
 
Details of any indemnity or option arrangement, or any agreement or 
understanding, formal or informal, relating to relevant securities which 
may be an inducement to deal or refrain from dealing entered into by the 
person making the disclosure and any party to the offer or any person 
acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state 'none'
 

(b) Agreements, arrangements or understandings relating to options or
derivatives

 
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating
to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state 'none'

 
(c) Attachments
 

Is a Supplemental Form 8 (Open Positions) attached?                NO
 


Date of disclosure:         14 August 2012
Contact name:               Dr. Sascha Spiegel
Telephone number:           0049 89 1220 7570
 

  
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is
available for consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
14.08.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Allianz Global Investors - Global Equity Business Unit Seidlstr. 24 - 24 a 80335 München Germany Phone: +49 (0)89 1220 7570 Fax: +49 (0)89 1220 7559 E-mail: sascha.spiegel@allianzam.com Internet: www.allianzgi.com ISIN: - Category Code: RET LSE Ticker: Sequence Number: 1166 Time of Receipt: Aug 14, 2012 13:38:03 End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Anleihe im Fokus

Die DF-Anleihe 7,875%

Mit der DF Forfait AG vom wachsenden Welthandel profitieren

- Zeichnungsfrist: 21.05. bis 24.05.2013
- Laufzeit: 7 Jahre
- Kupon: 7,875% p.a.
- Volumen: bis zu 30 Mio. Euro
- ISIN: DE000A1R1CC4

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

HELMA Eigenheimbau AG: Kaufen

Die HELMA Eigenheimbau AG präsentierte für das Geschäftsjahr 2012 Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen fairen Wert je Aktie von 22,75 € ermittelt. Ausgehend vom erwarteten 2013er-EPS von 1,64 € entspricht dies einem KGV von 8,4. Das Kurspotenzial beläuft sich auf nahezu 65%.

News im Fokus

Fresenius Medical Care AG & Co. KGaA: Bekanntmachung nach Art. 4 Abs. 2 der Verordnung (EG) Nr. 2273/2003

17. Mai 2013, 17:35

Aktueller Webcast

Allianz SE

Analysts' conference call on 1Q 2013

15. Mai 2013

Aktuelle Research-Studie

Original-Research: Plan Optik AG (von GBC AG): Kaufen Plan Optik AG

17. Mai 2013